Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Docetaxel

M Leahy¹, A Howell

¹Department of Medical Oncology, Christie Hospital, Manchester.

British Journal of Hospital Medicine

|February 4, 1997

Summary

This summary is machine-generated.

Paclitaxel, an early anticancer drug, showed effectiveness but caused significant toxicity. Newer drug docetaxel may offer improved efficacy and reduced side effects compared to paclitaxel.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A new, ultra-stable lab for nano-metrology of x-ray optics at Diamond Light Source.

The Review of scientific instruments·2025

Same author

Socioeconomic and ethnic disparities in preterm births in an English maternity setting: a population-based study of 1.3 million births.

BMC medicine·2024

Same author

An analysis of iris pattern as a risk factor for skin cancer development in immunosuppressed renal transplant recipients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Risk of HPV infection among dermatologists: Are we prepared?

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Sunscreen photoprotection: An observational study of cosmetic suitability and skin colour inclusivity.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Tamoxifen evolution.

British journal of cancer·2023

Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999

Same journal

Screening for breast cancer.

British journal of hospital medicine·1999

Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999

Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999

Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999

Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999

See all related articles

Area of Science:

Oncology
Pharmacology

Background:

Paclitaxel was the first taxoid anticancer drug.
Paclitaxel demonstrated anticancer activity but significant toxicity.

Purpose of the Study:

To compare the efficacy and toxicity of docetaxel with paclitaxel.
To evaluate docetaxel as a potentially improved taxoid therapy.

Main Methods:

Review of studies comparing paclitaxel and docetaxel.
Analysis of clinical trial data on taxoid efficacy and safety.

Main Results:

Docetaxel is a semisynthetic taxoid, part of an expanding drug class.
Emerging studies suggest docetaxel may be more effective than paclitaxel.
Preliminary data indicates docetaxel might have a better toxicity profile.

Conclusions:

Docetaxel represents a promising advancement in taxoid chemotherapy.
Further research is warranted to confirm docetaxel's superior therapeutic index.
Docetaxel could offer a more favorable treatment option for cancer patients.